• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外显子组测序确定 为非黏液性、非高级别浆液性上皮性卵巢癌的一个新的易感基因。 (原文中“identifies”后缺少具体内容)

Exome sequencing identifies as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.

作者信息

Dicks Ed M, Tyrer Jonthan P, Ezquina Suzana, Jones Michelle, Baierl John, Peng Pei-Chen, Diaz Michael, Goode Ellen, Winham Stacey J, Dörk Thilo, Van Gorp Toon, De Fazio Ana, Bowtell David, Odunsi Kunle, Moysich Kirsten, Pavanello Marina, Campbell Ian, Brenton James D, Ramus Susan J, Gayther Simon A, Pharoah Paul D P

机构信息

Department of Public Health and Primary Care, University of Cambridge, UK.

Department of Biomedical Sciences, Cedars-Sinai Medical Centre, Los Angeles, USA.

出版信息

medRxiv. 2024 Apr 3:2024.04.02.24304968. doi: 10.1101/2024.04.02.24304968.

DOI:10.1101/2024.04.02.24304968
PMID:38633804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11023670/
Abstract

Rare, germline loss-of-function variants in a handful of genes that encode DNA repair proteins have been shown to be associated with epithelial ovarian cancer with a stronger association for the high-grade serous hiostotype. The aim of this study was to collate exome sequencing data from multiple epithelial ovarian cancer case cohorts and controls in order to systematically evaluate the role of coding, loss-of-function variants across the genome in epithelial ovarian cancer risk. We assembled exome data for a total of 2,573 non-mucinous cases (1,876 high-grade serous and 697 non-high grade serous) and 13,925 controls. Harmonised variant calling and quality control filtering was applied across the different data sets. We carried out a gene-by-gene simple burden test for association of rare loss-of-function variants (minor allele frequency < 0.1%) with all non-mucinous ovarian cancer, high grade serous ovarian cancer and non-high grade serous ovarian cancer using logistic regression adjusted for the top four principal components to account for cryptic population structure and genetic ancestry. Seven of the top 10 associated genes were associations of the known ovarian cancer susceptibility genes , , , , and (false discovery probability < 0.1). A further four genes ( and ) had a false discovery rate of less than 0.1. Of these, was most strongly associated with the non-high grade serous histotype (P = 1.3×10, FDR = 9.1×10). Further support for this association comes from the observation that loss of function variants in this gene are also associated with age at natural menopause and Mendelian randomisation analysis shows an association between genetically predicted age at natural menopause and endometrioid ovarian cancer, but not high-grade serous ovarian cancer.

摘要

少数编码DNA修复蛋白的基因中罕见的种系功能丧失变异已被证明与上皮性卵巢癌相关,与高级别浆液性组织学类型的关联更强。本研究的目的是整理来自多个上皮性卵巢癌病例队列和对照的外显子组测序数据,以便系统评估全基因组编码功能丧失变异在上皮性卵巢癌风险中的作用。我们汇总了总共2573例非黏液性病例(1876例高级别浆液性和697例非高级别浆液性)和13925例对照的外显子组数据。对不同数据集应用了统一的变异调用和质量控制过滤。我们使用针对前四个主成分进行调整的逻辑回归,对罕见功能丧失变异(次要等位基因频率<0.1%)与所有非黏液性卵巢癌、高级别浆液性卵巢癌和非高级别浆液性卵巢癌进行逐个基因的简单负担检验,以考虑潜在的人群结构和遗传血统。前10个相关基因中有7个是已知的卵巢癌易感基因、、、、和的关联(错误发现概率<0.1)。另外四个基因(和)的错误发现率小于0.1。其中,与非高级别浆液性组织学类型关联最强(P = 1.3×10,FDR = 9.1×10)。对这种关联的进一步支持来自以下观察结果:该基因中的功能丧失变异也与自然绝经年龄相关,孟德尔随机化分析表明,遗传预测的自然绝经年龄与子宫内膜样卵巢癌相关,但与高级别浆液性卵巢癌无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cb3/11023670/423f1a1ce6f3/nihpp-2024.04.02.24304968v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cb3/11023670/3adf87f643ea/nihpp-2024.04.02.24304968v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cb3/11023670/423f1a1ce6f3/nihpp-2024.04.02.24304968v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cb3/11023670/3adf87f643ea/nihpp-2024.04.02.24304968v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cb3/11023670/423f1a1ce6f3/nihpp-2024.04.02.24304968v1-f0002.jpg

相似文献

1
Exome sequencing identifies as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.外显子组测序确定 为非黏液性、非高级别浆液性上皮性卵巢癌的一个新的易感基因。 (原文中“identifies”后缺少具体内容)
medRxiv. 2024 Apr 3:2024.04.02.24304968. doi: 10.1101/2024.04.02.24304968.
2
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.外显子组测序将HELB鉴定为非黏液性、非高级别浆液性上皮性卵巢癌的一个新的易感基因。
Eur J Hum Genet. 2025 Mar;33(3):297-303. doi: 10.1038/s41431-025-01786-0. Epub 2025 Feb 12.
3
Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.罕见种系基因变异与上皮性卵巢癌风险
Cancers (Basel). 2020 Oct 19;12(10):3046. doi: 10.3390/cancers12103046.
4
Population-based targeted sequencing of 54 candidate genes identifies as a susceptibility gene for high-grade serous ovarian cancer.基于人群的 54 个候选基因靶向测序发现 为高级别浆液性卵巢癌的易感基因。
J Med Genet. 2021 May;58(5):305-313. doi: 10.1136/jmedgenet-2019-106739. Epub 2020 Jun 16.
5
Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas.BRCA1和BRCA2致病变异在非高级别浆液性卵巢癌中的因果关系及功能相关性
J Pathol. 2024 Feb;262(2):137-146. doi: 10.1002/path.6218. Epub 2023 Oct 18.
6
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor.具有 SET 样形态的卵巢高级别浆液性癌:一种同源重组缺陷型肿瘤。
Hum Pathol. 2023 Nov;141:15-21. doi: 10.1016/j.humpath.2023.08.010. Epub 2023 Sep 9.
7
Low BRCA1 and BRCA2 Germline Mutation Rates in a French-Canadian Population with a Diagnosis of Epithelial Tubo-Ovarian Carcinoma.在诊断为上皮性输卵管-卵巢癌的法裔加拿大人群中,BRCA1 和 BRCA2 种系突变率较低。
J Obstet Gynaecol Can. 2022 Oct;44(10):1047-1053. doi: 10.1016/j.jogc.2022.06.005. Epub 2022 Jun 30.
8
The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit.通过对高级别浆液性卵巢癌患者进行平行检测,检测种系和体细胞 BRCA1/2 基因突变:一项全国性回顾性审计。
BJOG. 2022 Feb;129(3):433-442. doi: 10.1111/1471-0528.16975. Epub 2021 Nov 8.
9
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).连续卵巢癌患者(AGO-TR-1)中包括BRCA1/2在内的风险基因有害种系变异的患病率。
PLoS One. 2017 Oct 20;12(10):e0186043. doi: 10.1371/journal.pone.0186043. eCollection 2017.
10
Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.评估先前报道的风险因素在卵巢上皮性癌风险中的作用:一项孟德尔随机化分析。
PLoS Med. 2019 Aug 7;16(8):e1002893. doi: 10.1371/journal.pmed.1002893. eCollection 2019 Aug.

本文引用的文献

1
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer.高级别浆液性卵巢癌长期生存者的基因组和免疫景观。
Nat Genet. 2022 Dec;54(12):1853-1864. doi: 10.1038/s41588-022-01230-9. Epub 2022 Dec 1.
2
Exome sequencing and analysis of 454,787 UK Biobank participants.外显子组测序和分析 454787 名英国生物银行参与者。
Nature. 2021 Nov;599(7886):628-634. doi: 10.1038/s41586-021-04103-z. Epub 2021 Oct 18.
3
Genetic insights into biological mechanisms governing human ovarian ageing.遗传视角下人类卵巢衰老的生物学机制。
Nature. 2021 Aug;596(7872):393-397. doi: 10.1038/s41586-021-03779-7. Epub 2021 Aug 4.
4
Population-based targeted sequencing of 54 candidate genes identifies as a susceptibility gene for high-grade serous ovarian cancer.基于人群的 54 个候选基因靶向测序发现 为高级别浆液性卵巢癌的易感基因。
J Med Genet. 2021 May;58(5):305-313. doi: 10.1136/jmedgenet-2019-106739. Epub 2020 Jun 16.
5
Genome Maintenance by DNA Helicase B.DNA 解旋酶 B 的基因组维护
Genes (Basel). 2020 May 21;11(5):578. doi: 10.3390/genes11050578.
6
Neudesin: a neuropeptide hormone decreased in subjects with polycystic ovary syndrome.Neudesin:多囊卵巢综合征患者中减少的神经肽激素。
Gynecol Endocrinol. 2020 Oct;36(10):849-853. doi: 10.1080/09513590.2020.1751106. Epub 2020 Apr 21.
7
Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes.家族性高级别浆液性卵巢癌外显子组测序揭示罕见候选易感基因的异质性。
Nat Commun. 2020 Apr 2;11(1):1640. doi: 10.1038/s41467-020-15461-z.
8
The UK Biobank resource with deep phenotyping and genomic data.英国生物银行资源库,具有深度表型和基因组数据。
Nature. 2018 Oct;562(7726):203-209. doi: 10.1038/s41586-018-0579-z. Epub 2018 Oct 10.
9
Copy number signatures and mutational processes in ovarian carcinoma.卵巢癌中的拷贝数特征和突变过程。
Nat Genet. 2018 Sep;50(9):1262-1270. doi: 10.1038/s41588-018-0179-8. Epub 2018 Aug 13.
10
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes.异常 DNA 修复机制的基因组后果使卵巢癌组织型分层。
Nat Genet. 2017 Jun;49(6):856-865. doi: 10.1038/ng.3849. Epub 2017 Apr 24.